Cogent Biosciences, Inc. (COGT)

NASDAQ: COGT · Real-Time Price · USD

4.640

+0.130 (2.88%)

Apr 25, 2025, 4:00 PM EDT - Market closed

Cogent Biosciences Employees

Cogent Biosciences had 205 employees as of December 31, 2024. The number of employees increased by 41 or 25.00% compared to the previous year.

Employees

205

Change (1Y)

41

Growth (1Y)

25.00%

Revenue / Employee

n/a

Profits / Employee

-$1,248,093

Market Cap

528.65M

Employees Chart

Employees History

Date	Employees	Change	Growth
Dec 31, 2024	205	41	25.00%
Dec 31, 2023	164	26	18.84%
Dec 31, 2022	138	61	79.22%
Dec 31, 2021	77	62	413.33%
Dec 31, 2020	15	-	-

Related Stocks

Company Name	Employees
UnitedHealth Group	400,000
Johnson & Johnson	138,100
Thermo Fisher Scientific	125,000
Abbott Laboratories	114,000
AstraZeneca	92,900
Novartis AG	75,883
Merck & Co.	75,000
AbbVie	55,000

Employee Rankings

COGT News

2 days ago - Cogent Biosciences Presents Four Posters at the American Association for Cancer Research Annual Meeting 2025 and Announces Two New Leaders - GlobeNewsWire
4 weeks ago - Cogent Biosciences Announces Multiple Poster Presentations at 2025 American Association for Cancer Research (AACR) Annual Meeting - GlobeNewsWire
7 weeks ago - Cogent Biosciences Announces Participation in the Leerink Healthcare Conference - GlobeNewsWire
2 months ago - Cogent Biosciences Announces SUMMIT Continues to Showcase Powerful Symptomatic Improvement in NonAdvanced Systemic Mastocytosis Patients - GlobeNewsWire
2 months ago - Cogent Biosciences Reports Recent Business Highlights and Fourth Quarter and Full Year 2024 Financial Results - GlobeNewsWire
2 months ago - Cogent Biosciences Announces Bezuclastinib Poster in NonAdvanced Systemic Mastocytosis (NonAdvSM) at the 2025 AAAAI Annual Meeting - GlobeNewsWire
3 months ago - 3 Biotech Stocks With Notable Insider Buying - Seeking Alpha
3 months ago - Cogent Biosciences: Buy The Pullback For Bezuclastinib's 2025 SM And GIST Data - Seeking Alpha